Short Interest in Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) Rises By 1,368.8%

Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) saw a significant growth in short interest in the month of February. As of February 15th, there was short interest totalling 47,000 shares, a growth of 1,368.8% from the January 31st total of 3,200 shares. Based on an average daily trading volume, of 512,200 shares, the days-to-cover ratio is presently 0.1 days.

Biodexa Pharmaceuticals Trading Up 0.3 %

Biodexa Pharmaceuticals stock traded up $0.01 during mid-day trading on Thursday, reaching $3.49. The company had a trading volume of 89,405 shares, compared to its average volume of 240,358. The business’s 50-day simple moving average is $4.26. Biodexa Pharmaceuticals has a 1 year low of $3.36 and a 1 year high of $74.00.

Biodexa Pharmaceuticals Company Profile

Biodexa Pharmaceuticals Plc, a clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of Type 1 diabetes and rare/orphan cancers of the brain. Its lead product candidate Tolimidone, a selective activator of the lyn kinase enzyme, currently under Phase II studies for the treatment of Type 1 diabetes.